Comments
Loading...

ResMed

RMDNYSE
Logo brought to you by Benzinga Data
$242.98
4.952.08%
At Close: -
$242.98
00.00%
After Hours: 5:02 PM EDT
15 minutes delayed
Consensus Rating1
Overweight
Highest Price Target1
$300.00
Lowest Price Target1
$169.00
Consensus Price Target1
$221.00

ResMed (NYSE:RMD) Stock, Analyst Ratings, Price Targets, Forecasts

ResMed Inc has a consensus price target of $221 based on the ratings of 17 analysts. The high is $300 issued by Baird on January 13, 2022. The low is $169 issued by Morgan Stanley on October 27, 2023. The 3 most-recent analyst ratings were released by Wolfe Research, Needham, and RBC Capital on September 18, 2024, September 4, 2024, and August 2, 2024, respectively. With an average price target of $207.33 between Wolfe Research, Needham, and RBC Capital, there's an implied -14.67% downside for ResMed Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Jun
0
0
0
0
Jul
1
Aug
1
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.3
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Wolfe Research
RBC Capital
Keybanc
Mizuho
UBS

1calculated from analyst ratings

Analyst Ratings for ResMed

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for ResMed (RMD) stock?

A

The latest price target for ResMed (NYSE:RMD) was reported by Needham on September 18, 2024. The analyst firm set a price target for $0.00 expecting RMD to fall to within 12 months (a possible -100.00% downside). 29 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for ResMed (RMD)?

A

The latest analyst rating for ResMed (NYSE:RMD) was provided by Needham, and ResMed reiterated their hold rating.

Q

When was the last upgrade for ResMed (RMD)?

A

The last upgrade for ResMed Inc happened on October 27, 2023 when Morgan Stanley raised their price target to $169. Morgan Stanley previously had an equal-weight for ResMed Inc.

Q

When was the last downgrade for ResMed (RMD)?

A

The last downgrade for ResMed Inc happened on September 18, 2024 when Wolfe Research changed their price target from N/A to $180 for ResMed Inc.

Q

When is the next analyst rating going to be posted or updated for ResMed (RMD)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ResMed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ResMed was filed on September 18, 2024 so you should expect the next rating to be made available sometime around September 18, 2025.

Q

Is the Analyst Rating ResMed (RMD) correct?

A

While ratings are subjective and will change, the latest ResMed (RMD) rating was a reiterated with a price target of $0.00 to $0.00. The current price ResMed (RMD) is trading at is $242.98, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch